Thromboembolic and bleeding events pose a severe risk for patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Many factors can contribute to promoting the thrombotic event due to the interaction between platelets, leukocytes, and endothelium alterations. Moreover, a significant role can be played by cardiovascular risk factors (CV.R) such as cigarette smoking habits, hypertension, diabetes, obesity and dyslipidemia. In this study, we evaluated the impact that CV.R plays on thrombotic risk and survival in patients with PV and ET.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951352 | PMC |
| http://dx.doi.org/10.4084/MJHID.2020.008 | DOI Listing |
Publication Analysis
Top Keywords
cardiovascular risk
8
essential thrombocythemia
8
polycythemia vera
8
thrombotic risk
8
risk survival
8
risk essential
4
thrombocythemia polycythemia
4
vera thrombotic
4
risk
4
survival thromboembolic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!